Your browser doesn't support javascript.
loading
A Phase I Trial of the Anti-KIR Antibody IPH2101 and Lenalidomide in Patients with Relapsed/Refractory Multiple Myeloma.
Benson, Don M; Cohen, Adam D; Jagannath, Sundar; Munshi, Nikhil C; Spitzer, Gary; Hofmeister, Craig C; Efebera, Yvonne A; Andre, Pascale; Zerbib, Robert; Caligiuri, Michael A.
Afiliação
  • Benson DM; The Ohio State University Comprehensive Cancer Center, Columbus, Ohio. Don.benson@osumc.edu.
  • Cohen AD; University of Pennsylvania Abramson Cancer Center, Philadelphia, Pennsylvania.
  • Jagannath S; Mount Sinai School of Medicine, New York, New York.
  • Munshi NC; Dana Farber Cancer Institute, Boston, Massachusetts. Boston VA Healthcare System, Harvard Medical School, Boston, Massachusetts.
  • Spitzer G; St. Francis Hospital, Greenville, South Carolina.
  • Hofmeister CC; The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.
  • Efebera YA; The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.
  • Andre P; Innate Pharma, Marseille, France.
  • Zerbib R; Innate Pharma, Marseille, France.
  • Caligiuri MA; The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.
Clin Cancer Res ; 21(18): 4055-61, 2015 Sep 15.
Article em En | MEDLINE | ID: mdl-25999435
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Talidomida / Resistencia a Medicamentos Antineoplásicos / Anticorpos Monoclonais / Mieloma Múltiplo / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Talidomida / Resistencia a Medicamentos Antineoplásicos / Anticorpos Monoclonais / Mieloma Múltiplo / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2015 Tipo de documento: Article